| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Global Head of R&D | Global Head of R&D
1 company
Wang Lai is a President, Global Head of R&D at ONC. Recent filings cover 0 purchases and 46 sales.
Our model assigns Wang Lai a middling insider score of 50/100, based on 27 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -10.2%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | ONC Beone Medicines AG | President, Global Head of R&D | Sell | 1,068 | $276.74 | $295,552.98 | -100% | +32.4% | - | |
| Jun 16, 2026 | ONC Beone Medicines AG | President, Global Head of R&D | Sell | 1,169 | $265.39 | $310,235.88 | -100% | +34.1% | - | |
| Jun 11, 2026 | ONC Beone Medicines AG | President, Global Head of R&D | Sell | 756 | $261.00 | $197,317.59 | -100% | +34.9% | - | |
| Jun 8, 2026 | ONC Beone Medicines AG | President, Global Head of R&D | Sell | 1,367 | $269.38 | $368,246.83 | -100% | +29.8% | - | |
| Sep 9, 2025 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell10b5-1 | 5,000 | $350.06 | $1,750,311.50 | -100% | -7.0% | -0.0% | |
| Jul 30, 2025 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell10b5-1 | 4,300 | $302.65 | $1,301,375.41 | -100% | +5.6% | - | |
| Jul 18, 2025 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell10b5-1 | 700 | $300.00 | $210,000.00 | -100% | +8.0% | +7.8% | |
| Jun 23, 2025 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell | 1,028 | $260.00 | $267,280.00 | -100% | +31.2% | +4.9% | |
| Jun 17, 2025 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell | 1,647 | $262.11 | $431,699.06 | -100% | +30.8% | +4.1% | |
| Jun 6, 2025 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell | 1,402 | $252.39 | $353,853.30 | -100% | +24.6% | - |